These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 3660895)

  • 21. Some aspects of medical management of gastrointestinal disease. I.
    Badley BW
    Can Med Assoc J; 1975 Jan; 112(2):200-4, 206. PubMed ID: 234288
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of pirenzepine on L--amino acids stimulated gastric acid secretion and serum gastrin levels in peptic ulcer disease in men.
    Bertoglio S; Anfossi A; Arnulfo G; Valentini P; Berti Riboli E
    Scand J Gastroenterol Suppl; 1982; 72():179-84. PubMed ID: 6957988
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Usefulness of proton pump inhibitor (PPI) maintenance therapy for patients with H. pylori-negative recurrent peptic ulcer after eradication therapy for H. pylori: pathophysiological characteristics of H. pylori-negative recurrent ulcer scars and beyond acid suppression by PPI.
    Ohara T; Morishita T; Suzuki H; Masaoka T; Ishii H
    Hepatogastroenterology; 2004; 51(56):338-42. PubMed ID: 15086153
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cisapride--more selective than metoclopramide.
    Drug Ther Bull; 1990 Nov; 28(23):89-90. PubMed ID: 2131232
    [No Abstract]   [Full Text] [Related]  

  • 25. Inhibition of peptic ulcer relapse by ranitidine and ecabet independently of eradication of Helicobacter pylori: a prospective, controlled study versus ranitidine.
    Koizumi W; Tanabe S; Imaizumi H; Kida M; Ohida M; Koshida Y; Mitomi H; Hosaka Y; Nagaba S; Sasaki T; Higuchi K; Saigenji K
    Hepatogastroenterology; 2003; 50(50):577-81. PubMed ID: 12749277
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of anticholinergics (atropine, glycopyrrolate) and prokinetics (metoclopramide, cisapride) on gastric motility in beagles and labrador retrievers.
    Burger DM; Wiestner T; Hubler M; Binder H; Keiser M; Arnold S
    J Vet Med A Physiol Pathol Clin Med; 2006 Mar; 53(2):97-107. PubMed ID: 16466463
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of gastric acid secretion by selective and nonselective anticholinergics.
    Feldman M
    Gastroenterology; 1984 Feb; 86(2):361-6. PubMed ID: 6360787
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of ranitidine on healing of peptic ulcer: a 2-month study.
    Leroux P; Farley A; Archambault A; Pilon G; Gosselin D; Paré P; Lévesque D; Sherbaniuk R; Thomson AB
    Am J Gastroenterol; 1983 Apr; 78(4):227-30. PubMed ID: 6301262
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ulcer disease of the upper gastrointestinal tract.
    Meeroff JC
    Hosp Pract (Off Ed); 1984 Oct; 19(10):177-80, 190, 192 passim. PubMed ID: 6148348
    [No Abstract]   [Full Text] [Related]  

  • 30. Influence of atropine, pirenzepine and cimetidine on nocturnal gastro-intestinal motility and gastric acid secretion.
    Lederer PC; Thiemann R; Femppel J; Domschke W; Lux G
    Scand J Gastroenterol Suppl; 1982; 72():131-7. PubMed ID: 6957981
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pirenzepine in the treatment of peptic ulcer disease. Review and commentary.
    Bianchi Porro G; Petrillo M
    Scand J Gastroenterol Suppl; 1982; 72():229-36. PubMed ID: 6753117
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of protective drugs in the prevention of ulcer relapse.
    Ota S; Terano A
    J Gastroenterol; 1994 Jul; 29 Suppl 7():139-40. PubMed ID: 7921147
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Treatment of peptic ulcer with i.v. ranitidine. A treatment possibility in special cases. Experiences from general practice].
    Kemmer R; Taenzer HJ
    Fortschr Med; 1984 Feb; 102(8):201-2. PubMed ID: 6086476
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cisapride compared with ranitidine in the treatment of functional dyspepsia.
    Carvalhinhos A; Fidalgo P; Freire A; Matos L
    Eur J Gastroenterol Hepatol; 1995 May; 7(5):411-7. PubMed ID: 7614103
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of H. pylori status on gastric ulcer healing in patients continuing nonsteroidal anti-inflammatory therapy and receiving treatment with lansoprazole or ranitidine.
    Campbell DR; Haber MM; Sheldon E; Collis C; Lukasik N; Huang B; Goldstein JL
    Am J Gastroenterol; 2002 Sep; 97(9):2208-14. PubMed ID: 12358234
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prokinetic agents: a key in the future of gastroenterology.
    Reynolds JC
    Gastroenterol Clin North Am; 1989 Jun; 18(2):437-57. PubMed ID: 2668178
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Antisecretory drugs and prophylaxis of secondary gastrointestinal effects associated with the consumption of non steroid anti-inflammatory drugs].
    Lanas A; Arroyo MT
    Med Clin (Barc); 2000; 114 Suppl 2():57-62. PubMed ID: 10916808
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effects of various prokinetic drugs on gastrointestinal transit times in patients with progressive systemic scleroderma].
    Folwaczny C; Läritz M; Meurer M; Endres SP; König A; Schindlbeck N
    Z Gastroenterol; 1997 Oct; 35(10):905-12. PubMed ID: 9432812
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combination of ranitidine and cisapride in the treatment of reflux oesophagitis.
    McKenna CJ; Mills JG; Goodwin C; Wood JR
    Eur J Gastroenterol Hepatol; 1995 Sep; 7(9):817-22. PubMed ID: 8574711
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The influence of various secretory inhibitors on peptic activity.
    Gabryelewicz A; Laszewicz W; Sarosiek J
    Scand J Gastroenterol Suppl; 1980; 66():79-85. PubMed ID: 6264587
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.